Lyndra said that it will use the fresh financing to kick off phase II of clinical trials, expand its phase I pipeline and scale up its manufacturing capacity. The post HOPU, Polaris join $55m Series B round for Lyndra Therapeutics appeared first on DealStreetAsia.